US Stock MarketDetailed Quotes
CYTO Altamira Therapeutics
- 1.6200
- +0.0200+1.25%
Trading Apr 26 12:00 ET
3.63MMarket Cap-187P/E (TTM)
1.6300High1.5100Low48.15KVolume1.5400Open1.6000Pre Close75.73KTurnover2.17%Turnover RatioLossP/E (Static)2.24MShares28.400052wk High0.51P/B3.59MFloat Cap1.350052wk Low--Dividend TTM2.22MShs Float636800.0000Historical High--Div YieldTTM7.50%Amplitude1.3500Historical Low1.5720Avg Price1Lot Size
About Altamira Therapeutics Company
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the Switzerland and Australia geographical segments. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
Company Profile
SymbolCYTO
Company NameAltamira Therapeutics
Listing DateAug 6, 2014
Issue Price6.00
Founded2003
CEOMr. Thomas Meyer
MarketNASDAQ
Employees12
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressClarendon House,2 Church Street
CityHamilton
ProvinceHamilton
CountryBermuda
Zip CodeHM 11
Phone1-441-295-5950
Company Executives
- Name
- Position
- Salary
- Thomas Meyer
- Chairman of the Board and Chief Executive Officer
- 654.87K
- Covadonga Paneda
- Chief Operating Officer
- --
- Marcel Gremaud
- Chief Financial Officer
- --
- Dr. Alain Henri Munoz
- Independent Director
- 49.91K
- Mats Blom
- Independent Director
- 49.91K
- Margrit Schwarz
- Independent Director
- 49.91K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
